These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3279620)

  • 1. Xenotransplantation.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):325-31. PubMed ID: 3279620
    [No Abstract]   [Full Text] [Related]  

  • 2. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation.
    Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1995 Apr; 27(2):1583-4. PubMed ID: 7725417
    [No Abstract]   [Full Text] [Related]  

  • 3. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):741. PubMed ID: 8623376
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal inoculation with donor cells in cardiac xenotransplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1996 Nov; 62(5):1360-3. PubMed ID: 8893569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a concordant xenogeneic splenocyte injection model for the dynamic study of the marginal zone in the spleen.
    Yasutomi M; Ito M; Hayashi S; Ohtsuka S; Namii Y; Uchida K; Yokoyama I; Takagi H
    J Heart Lung Transplant; 1998 May; 17(5):452-9. PubMed ID: 9628563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rejection and accommodation in the hamster-to-rat heart transplantation model.
    Bouwman E; Scheringa M; Nio D; IJzermans JN; Marquet RL
    Transplant Proc; 1994 Apr; 26(2):992-3. PubMed ID: 8171723
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of the malononitrilamide X 920715 as compared with leflunomide in cardiac allo- and xenotransplantation in rats.
    Lin Y; Segers C; Waer M
    Transplant Proc; 1996 Dec; 28(6):3036. PubMed ID: 8962178
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation.
    Namii Y; Yasutomi M; Hayashi S; Ito M; Ohtsuka S; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1996 Apr; 28(2):709-10. PubMed ID: 8623358
    [No Abstract]   [Full Text] [Related]  

  • 10. Timing of spleen activation in rats treated with cyclophosphamide (CyP): its role in a hamster-to-rat heterotopic heart xenotransplantation (HHX) model.
    Catena M; Lattanzio G; Maggiano N; Musiani P; Ferla G
    Transplant Proc; 1994 Jun; 26(3):1182-3. PubMed ID: 8029878
    [No Abstract]   [Full Text] [Related]  

  • 11. Natural killer cells, antibody-dependent cellular cytotoxicity, and complement synthesis by the xenograft itself play a role in xenograft rejection.
    Lin Y; Sobis H; Vandeputte M; Waer M
    Transplant Proc; 1995 Feb; 27(1):286-7. PubMed ID: 7879005
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 13. Xenogeneic bone marrow transplantation in the hamster-to-rat model prevents rejection of subsequently grafted hamster hearts.
    Bouwman E; Scheringa M; Marquet RL
    Transplant Proc; 1996 Apr; 28(2):681-2. PubMed ID: 8623342
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation.
    Hayashi S; Ito M; Yasutomi M; Namii Y; Yokoyama I; Uchida K; Takagi H
    J Heart Lung Transplant; 1995; 14(3):579-84. PubMed ID: 7544621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orthotopic heart-lung xenotransplantation using primates].
    Asai Y; Hass G; Cosimo S; Sadeghi AM; Drinkwater D; Laks H
    Kyobu Geka; 1988 Dec; 41(13):1061-4. PubMed ID: 3146665
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative immunopathologic study of hyperacute rejection in naive and sensitized rodent cardiac xenograft models.
    Wu GD; Cramer DV; Chapman FA; Wang HK; Chien K; Cole J; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):464-5. PubMed ID: 8438380
    [No Abstract]   [Full Text] [Related]  

  • 17. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F; Shen J; Chong A; Liu W; Foster P; Blinder HL; Sankary H; McChesney L; Mital D; Williams JW
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
    Magee JC; Collins BH; Harland RC; Bollinger RR; Frank MM; Platt JL
    Transplant Proc; 1995 Feb; 27(1):271. PubMed ID: 7878999
    [No Abstract]   [Full Text] [Related]  

  • 19. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
    Hasan RI; Sriwatanawongsa V; Wallwork J; White DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):421-2. PubMed ID: 8438362
    [No Abstract]   [Full Text] [Related]  

  • 20. Simian-type blood group antigens in nonhuman primate cardiac xenotransplantation.
    Michler RE; Marboe CC; Socha WW; Moor-Jankowski J; Reemtsma K; Rose EA
    Transplant Proc; 1987 Dec; 19(6):4456-62. PubMed ID: 3321600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.